142 related articles for article (PubMed ID: 12526170)
1. Trans-splicing vectors expand the packaging limits of adeno-associated virus for gene therapy applications.
Duan D; Yue Y; Yan Z; Engelhardt JF
Methods Mol Med; 2003; 76():287-307. PubMed ID: 12526170
[No Abstract] [Full Text] [Related]
2. Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison.
Duan D; Yue Y; Engelhardt JF
Mol Ther; 2001 Oct; 4(4):383-91. PubMed ID: 11592843
[TBL] [Abstract][Full Text] [Related]
3. Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors.
Lai Y; Yue Y; Liu M; Ghosh A; Engelhardt JF; Chamberlain JS; Duan D
Nat Biotechnol; 2005 Nov; 23(11):1435-9. PubMed ID: 16244658
[TBL] [Abstract][Full Text] [Related]
4. Targeted integration by adeno-associated virus.
Weitzman MD; Young SM; Cathomen T; Samulski RJ
Methods Mol Med; 2003; 76():201-19. PubMed ID: 12526165
[No Abstract] [Full Text] [Related]
5. Dual vector expansion of the recombinant AAV packaging capacity.
Duan D; Yue Y; Engelhardt JF
Methods Mol Biol; 2003; 219():29-51. PubMed ID: 12596997
[No Abstract] [Full Text] [Related]
6. Trans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection efficiency.
Xu Z; Yue Y; Lai Y; Ye C; Qiu J; Pintel DJ; Duan D
Hum Gene Ther; 2004 Sep; 15(9):896-905. PubMed ID: 15353044
[TBL] [Abstract][Full Text] [Related]
7. Efficient trans-splicing in the retina expands the utility of adeno-associated virus as a vector for gene therapy.
Reich SJ; Auricchio A; Hildinger M; Glover E; Maguire AM; Wilson JM; Bennett J
Hum Gene Ther; 2003 Jan; 14(1):37-44. PubMed ID: 12573057
[TBL] [Abstract][Full Text] [Related]
8. Double strand interaction is the predominant pathway for intermolecular recombination of adeno-associated viral genomes.
Yue Y; Duan D
Virology; 2003 Aug; 313(1):1-7. PubMed ID: 12951015
[TBL] [Abstract][Full Text] [Related]
9. Development and optimization of adeno-associated virus vector transfer into the central nervous system.
During MJ; Young D; Baer K; Lawlor P; Klugmann M
Methods Mol Med; 2003; 76():221-36. PubMed ID: 12526166
[No Abstract] [Full Text] [Related]
10. Recombinant adeno-associated viral vector production using stable packaging and producer cell lines.
Mathews LC; Gray JT; Gallagher MR; Snyder RO
Methods Enzymol; 2002; 346():393-413. PubMed ID: 11883082
[No Abstract] [Full Text] [Related]
11. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice.
Koo T; Popplewell L; Athanasopoulos T; Dickson G
Hum Gene Ther; 2014 Feb; 25(2):98-108. PubMed ID: 24191945
[TBL] [Abstract][Full Text] [Related]
12. Packaging systems for adeno-associated virus vectors.
Trempe JP
Curr Top Microbiol Immunol; 1996; 218():35-50. PubMed ID: 8794244
[No Abstract] [Full Text] [Related]
13. Can Adeno-Associated Viral Vectors Deliver Effectively Large Genes?
Tornabene P; Trapani I
Hum Gene Ther; 2020 Jan; 31(1-2):47-56. PubMed ID: 31916856
[TBL] [Abstract][Full Text] [Related]
14. Synthetic intron improves transduction efficiency of trans-splicing adeno-associated viral vectors.
Lai Y; Yue Y; Liu M; Duan D
Hum Gene Ther; 2006 Oct; 17(10):1036-42. PubMed ID: 17007565
[TBL] [Abstract][Full Text] [Related]
15. Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy.
Yan Z; Zhang Y; Duan D; Engelhardt JF
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6716-21. PubMed ID: 10841568
[TBL] [Abstract][Full Text] [Related]
16. Innovative vector design: cross-packaged, self-complementary and now trans-splicing AAV vectors.
Byrne BJ
Hum Gene Ther; 2009 Nov; 20(11):1224-5. PubMed ID: 20374097
[No Abstract] [Full Text] [Related]
17. Hybrid adeno-associated virus bearing nonhomologous inverted terminal repeats enhances dual-vector reconstruction of minigenes in vivo.
Yan Z; Lei-Butters DC; Zhang Y; Zak R; Engelhardt JF
Hum Gene Ther; 2007 Jan; 18(1):81-7. PubMed ID: 17181493
[TBL] [Abstract][Full Text] [Related]
18. Optimization of packaging of adeno-associated virus gene therapy vectors using plasmid transfections.
Chirico J; Trempe JP
J Virol Methods; 1998 Dec; 76(1-2):31-41. PubMed ID: 9923737
[TBL] [Abstract][Full Text] [Related]
19. A novel gene expression control system and its use in stable, high-titer 293 cell-based adeno-associated virus packaging cell lines.
Qiao C; Wang B; Zhu X; Li J; Xiao X
J Virol; 2002 Dec; 76(24):13015-27. PubMed ID: 12438627
[TBL] [Abstract][Full Text] [Related]
20. Novel strategy for generation and titration of recombinant adeno-associated virus vectors.
Shiau AL; Liu PS; Wu CL
J Virol; 2005 Jan; 79(1):193-201. PubMed ID: 15596815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
